ABSTRACT Background: Elevated serum low-density lipoprotein (LDL) cholesterol is a predictor of cardiovascular disease events, and the quality of dietary fat is known to influence serum levels of LDL cholesterol in children. Interindividual differences in response to diet exist, but the underlying genetic factors remain largely unknown. Objective: We aimed to identify genetic variants that modify the variation in serum lipid response to dietary fat quality. Design: We used data from 2 longitudinal Finnish cohorts designed to study risk factors for cardiovascular diseases. Large-scale genotyping was performed with Metabochip in a long-term randomized controlled dietary intervention trial, the Special Turku Coronary Risk Factor Intervention Project (STRIP), for discovery of genetic polymorphisms. The observational Cardiovascular Risk in Young Finns Study (YFS) with genome-wide genetic data was used as a replication sample for the initial findings. Dietary records were used to calculate the ratio of unsaturated to saturated fats. Interaction models and multiple follow-ups were used in the analysis. Results: In the STRIP cohort, a variant within the PARK2 locus, rs9364628, showed moderate interaction with dietary fat quality and a consistent direction of effect in both scans on serum LDLcholesterol concentration in children aged 5 and 7 y (P , 0.0084 and P , 0.0057, respectively). In the YFS cohort, we were unable to replicate the initial discovery signal, but rs12207186 within the PARK2 locus and dietary lipid quality had a stronger interaction effect on serum LDL-cholesterol concentration (P , 9.44 3 10 -5 ) than did rs9364628 in children aged 6 y. Conclusion: This genotyping study involving 2 cohorts of healthy Finnish children indicates a possible interaction between PARK2 variants and dietary fat quality on serum LDL-cholesterol concentration. This trial was registered at clinicaltrials.gov as NCT00223600.
INTRODUCTION
Atherosclerosis is a major cause of mortality and morbidity in industrialized nations (1) . Atherosclerosis develops across the life course, with evidence of the first atherosclerotic lesions, fatty streaks, found in the arterial walls of children aged as young as 3 y (2). Age, serum cholesterol, blood pressure, and smoking are the major risk factors for atherosclerosis (3) . Because most serum cholesterol is transported in circulating LDL, LDL-cholesterol concentration plays an important role in the development and progression of atherosclerosis.
The synthesis rate of total body cholesterol in healthy adults is approximately 8.4 mg/kg per day but may vary up to 24% depending on the diet (4) . In addition to dietary cholesterol intake, saturated fat consumption is one of the most important dietary factors that can illicit fluctuations in serum LDL cholesterol and total cholesterol concentrations. Dietary lauric, myristic, and palmitic acids (12:0, 14:0, and 16:0, respectively) raise plasma LDL cholesterol, whereas stearic acid (18:0) and fatty acids containing fewer than 12 carbon atoms have a minimal effect. Furthermore, LDL-cholesterol concentration is lowered when monounsaturated fats rich in oleic acid are exchanged for saturated fats. From individual dietary fatty acids, linoleic acid may be the most influential because it appears to determine whether a specific saturated fatty acid has on observable effect on the serum lipid profile (5, 6) . Because certain fatty acids tend to raise LDL cholesterol and others lower it, the dietary unsaturatedto-saturated fat ratio of (MUFA + PUFA):SFA is a useful metric to describe the tendency of the diet to elevate serum LDLcholesterol concentration.
Previous studies support the concept that genes alter serum lipid response to dietary fats, as suggested by APOE haplotypedependent effects of dietary fats on serum lipid metabolism (7) . Genome-wide association studies (GWASs) 5 have been successful in identifying common variants associated with complex traits. However, there are few studies on the age-dependent effects of genetic variation. For example, different genes might be responsible for the phenotype of interest during distinct developmental phases, such as childhood and puberty. The ability of genetic association studies to identify novel variants might be improved if different age groups were considered.
The purpose of this study was to identify genetic variants that modify the variation in serum lipid response to dietary fat quality and to gain insight to yet unknown lipid biology. It is of importance to study lipid biology in children because early atherosclerotic lesions are formed in childhood, and LDL cholesterol is an important priming factor in the development of atherosclerosis.
SUBJECTS AND METHODS

The Special Turku Coronary Risk Factor Intervention Project cohort
The Special Turku Coronary Risk Factor Intervention Project (STRIP), registered at clinicaltrials.gov as NCT00223600, was designed to examine the influences of dietary counseling on children's dietary intake, serum lipid profile, growth, and development. The participants were enrolled at their 6-mo visit at well-baby clinics in Turku, Finland, in 1990-92 and randomly allocated to an intervention group or a control group. During the first years, dietary intervention was given every 3-6 mo primarily to the parents. From age 7 y onward, progressively more intervention was given directly to the child. The target of the intervention was fat intake 30-35% of daily energy, (MUFA + PUFA) to SFA ratio of 2:1, and cholesterol intake ,200 mg/d. With subsequent visits, the families were gradually directed toward the targeted dietary fat composition. The intervention was individualized and suggestions were made based on the child's dietary records. In addition, the children were not encouraged to use any dietary supplements during the intervention. Although STRIP was designed as an intervention study, we ignored the intervention and control group division for this article, and the groups were defined according to the dietary characteristics as described below.
Dietary data and laboratory measurements
From the age of 8 mo to 7 y, families biannually kept a 4-d food record of their child's food intake. At study visits, the records were reviewed by a nutritionist, and nutrient intakes were analyzed with a Micro-Nutrica program, which uses the Food and Nutrient Database of the Social Insurance Institution and calculates 66 nutrients of commonly used foods and dishes in Finland (8) . Supplemental vitamins and minerals were not included in the dietary data.
The cohort was divided into 2 groups based on the ratio of dietary unsaturated fat to saturated fat [(MUFA + PUFA):SFA]. The median of this ratio was used as a cutoff point to discern those with low and high unsaturated to saturated fat ratios. The dietary intake of fat was expressed as a percentage of energy from total daily energy intake. Sex-specific z scores were used for serum LDL-cholesterol concentration and dietary fat quality in all analyses. Weight, BMI, waist, or waist to hip ratio did not have significant effects on serum lipid concentration, so they were not used to adjust variables after z transformation.
Venous blood samples were drawn at 7 mo, 13 mo, and 2 y of age and annually thereafter until age 19 y, with the exception of ages 6 and 8 y. Samples drawn after age 5 y were obtained in the fasting state (9) .
Genotyping
A total of 666 subjects were genotyped with the Illumina custom Metabochip array, including 196,725 single-nucleotide polymorphisms (SNPs) selected based on GWAS meta-analyses of 23 cardiovascular disease-related traits (10) . SNPs with minor allele frequency ,5% and with more than 5% missing genotype per variant were excluded. To account for errors in sample processing, individuals with more than 5% missing genotype data were also excluded from further analysis. To account for genotyping errors, we excluded SNPs with a Hardy-Weinberg P value ,1 3 10
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. After applying these filters, a final list of 125,848 SNPs passed the quality control criteria.
Cardiovascular Risk in Young Finns Study
The Cardiovascular Risk in Young Finns Study (YFS) is a multicenter follow-up study that began in 1980 with randomly chosen subjects from the cities of Helsinki, Turku, Tampere, Oulu, and Kuopio in addition to their rural surroundings. In the beginning, 4320 children and adolescents aged 3-18 y were invited to participate, with 3596 attending clinics for the first crosssectional survey held in 1980. Follow-up studies that included physical examination and measurements of cardiovascular disease risk factors were conducted in 1983, 1986, 2001, 2007, and 2011 .
Dietary data
Detailed dietary information was obtained by using the 48-h recall method. Intake of energy nutrients was calculated from these data by using food composition tables (11) . The subjects were divided into 2 groups by using the median of the YFS cohort fat quality ratio as a cutoff.
Nuclear magnetic resonance metabolomics
Nuclear magnetic resonance (NMR) spectroscopy analyses were available for 2247 and 2160 serum samples in 2001 and 5 Abbreviations used: FDR, false discovery rate; GWAS, genome-wide association study; LD, linkage disequilibrium; NMR, nuclear magnetic resonance; SNP, single-nucleotide polymorphism; STRIP, Special Turku Coronary Risk Factor Intervention Project; YFS, Cardiovascular Risk in Young Finns Study.
2007, respectively, when the individuals were aged 30-48 y. Fourteen LDL subclass measures were assessed for interaction with genetic variants (in adult subjects because measurements were not available in childhood). These data are part of the NMR-based metabolite profiling that has recently been used in various epidemiologic and genetic studies (12) (13) (14) and for which the details of experimentation have been described (15, 16) . The average particle diameters for large, medium, and small LDL subclasses are 25.5 nm, 23.0 nm, and 18.7 nm, respectively.
Genotyping in the YFS
The genotyping in the YFS cohort (n = 2442) was performed with the custom-built Illumina BeadChip 670K containing 670,000 SNPs and copy-number variant probes. Genotypes were called by using Illumina's clustering algorithm. Imputation was performed with MACH software and HapMap release 22 (Center for Statistical Genetics, University of Michigan) as a reference panel, resulting in total of 2.5 million SNPs.
Statistical analyses
In the discovery phase, we performed 2 separate genetic interaction scans (Metabochip-wide interaction analysis) in the STRIP cohort for LDL-cholesterol concentration at 5 and 7 y of age with Plink v1.07 software (17, 18) . LDL cholesterol distribution was assessed for outliers, and the KolmogorovSmirnov test was used to assess the normality of the distribution. Genotype, dietary fat quality, and LDL-cholesterol concentration were available from 539 and 549 participants aged 5 and 7 y, respectively. The maximum number of individuals was included in these 2 scans, and a total of 483 subjects had complete data on 2 age points. To assess whether SNPs modify the relation between fat quality group and LDL cholesterol, we searched for SNPs that replicated in both scans with a consistent effect direction and P , 0.01. The 0.01 limit was chosen based on the simulation study. Plink software was used to calculate genomic inflation factor based on x 2 statistics. In the replication phase, we selected all markers 6200 kB from a marker found in the discovery phase and tested whether those markers modified the relation between fat quality group and LDL cholesterol in 6-and 9-y-old children. Probabel (19) software (GenABEL project) was used to test interaction in case of imputed SNPs. P values for Probabel output were calculated by dividing bs with corresponding standard errors and estimating the P value from the normal distribution. The false discovery rate (FDR) was used to correct for multiple testing.
Input for the Plink software and further analyses after the large-scale genome scan were performed with SAS 9.2 software (SAS Institute).
Simulation study
To assess the possibility of false-positive interactions in our study design, we generated 2 random phenotype data sets with R software version 2.11.1 (The R Project). The 2 random phenotypes had equal between-measurement correlation as our real data. These simulated phenotypes were sampled from the normal distribution and had no true genotype-fat quality interaction. The 2 simulated phenotypes were used to run interaction analyses with real genotype data to assess the possibility of false-positive interactions in our study design. In this simulation, 3 SNPs fulfilled our selection criteria (P , 0.01 in both interaction analyses and consistent direction of effect) for the replication study.
Ethical statement
The recommendations of the Declaration of Helsinki were followed in both studies. All subjects or their parents provided written informed consent, and the study protocol was approved by a local ethics committee.
RESULTS
Characteristics of the STRIP study participants are presented in Table 1 . Five-year-old boys were significantly taller and had lower LDL and total cholesterol concentration than 5-y-old girls. At age 7 y, a statistically significant difference was also noted in serum triglyceride concentration between boys and girls. The median of fat quality ratio, which was used as a cutoff to divide the cohort into fat quality groups, was 1.23 and 1.28 in 5-and 7-y-old girls, respectively. In boys aged 5 and 7 y, the fat quality median was 1.21 and 1.31, respectively.
Discovery analyses
In the STRIP cohort, genetic interaction scans were performed for genotype-dietary fat quality interaction on serum LDLcholesterol concentration at 2 age points. A total of 21 SNPs replicated in both interaction scans with P , 0.01 and had a consistent direction of effect. The results are shown in Table 2 . Seven of the 21 SNPs were located inside a known gene. Of these 7 genes, SLC22A1 has been previously linked to linoleic acid metabolism, whereas BAIAP2L2 is involved in glycosphingolipid biosynthesis. Other loci previously linked to lipid metabolism include PARK2. The interaction between PARK2 variant rs9364628 and the dietary fat quality ratio is described in Figure 1 . When the dietary fat quality ratio was high, the C allele was associated with a higher LDL-cholesterol concentration. On the other hand, the C allele was associated with a lower LDL-cholesterol concentration when the dietary fat quality ratio was low. Genomic inflation factors calculated by Plink software were 1.09 and 1.00 in the scans performed for 5-y-olds and 7-y-olds, respectively.
Replication analyses
We replicated the genomic region of 6200 kB surrounding each of the 21 discovery signals in the YFS cohort. Because different genotyping platforms were used in the discovery and replication studies, the discovery SNP itself might not be included in the replication analysis.
The replication results are presented in Table 3 . Of the 21 loci selected for replication, one locus (PARK2) contained SNPs with a statistically significant FDR in our replication analysis. The strongest interaction signal from this locus was rs12207186 with a P value of 9.44 3 10
25 and an FDR of 0.023. The 200-kB region surrounding the discovery signal included 487 SNPs in our replication data set. The least squares means of LDL-cholesterol concentration in 3-to 9-y-old YFS subjects are depicted in Figure 2 . The overall interaction P value was not significant. However, consistent with the discovery analysis, the dietary fat quality ratio seemed to have the largest effect on serum LDLcholesterol concentration in subjects with the TT genotype.
Secondary analyses
To assess the interactions of individual fatty acids and rs9364628 on serum LDL-cholesterol concentration, we fitted the linear interaction model to the data for the 2 STRIP age groups. The interaction between linoleic acid and rs9364628 on LDLcholesterol concentration was statistically significant in both age groups. Interaction terms that replaced linoleic acid with MUFAs and PUFAs were statistically significant among those aged 7 y but not those aged 5 y ( Table 4) . P values and bs for the interaction term were 0.040 and 0.237 in 5-y-olds and 0.009 and 0.300 in 7-y-olds, respectively. To assess the biochemical pathways through which genetic variants might regulate lipid metabolism, we studied whether polymorphisms at the PARK2 locus have interactions with dietary fat quality on 14 different LDL subclasses measured from NMR spectrometry in adults from the YFS ( Table 5) . Statistically significant interactions were observed between rs9364628 and dietary fat quality on concentration of small LDL particles (average diameter 18.7 nm) and concentration of total lipids in small LDL. These interactions are depicted in Supplemental Figures 1 and 2 . For small LDL particle concentration, the highest values are seen in individuals with the TT genotype and a low-quality fat diet, whereas in individuals with the TT genotype and a high-quality fat diet, the small LDL concentration is low (see Supplemental Figure 1 ). A similar pattern is seen in total lipids of small LDL particles (see Supplemental Figure 2 ).
DISCUSSION
We identified and replicated a genomic region around the PARK2 gene that may contribute to how dietary fatty acid composition modifies serum LDL-cholesterol concentration in children. The difference between dietary fat quality groups was consistently greater in PARK2 variant rs9364628 TT homozygotes than in CC homozygotes or heterozygotes. On the basis of interaction analysis of individual fatty acids, linoleic acid might be the most important contributor in the observed interaction between SNP and fat quality on LDL-cholesterol concentration. Our additional results from analyses of NMR data indicate that among all LDL particle subclasses, PARK2 modifies the relation between dietary fat quality ratio and the most atherogenic lipid particles (small LDL particles). The data suggest that the genetic effect (i.e., the increased small LDL particle concentration associated with TT genotype) is diluted in the presence of a highquality fat diet. Experimental studies have previously shown that the PARK2 knockout mice have altered lipid metabolism compared with wild-type mice (20) . Therefore, the current evidence indicates that PARK2 may have extraneuronal effects in humans, and its role in lipid metabolism should be further evaluated in humans. PARK2 encodes a protein called Parkin, and its role has been extensively studied in the development of Parkinson disease. Emerging data have pointed to a complex interplay between serum lipid homeostasis and pathophysiology of the disease. Epidemiologic data suggest that lower circulating levels of cholesterol may increase the risk of Parkinson disease. In addition, a high intake of unsaturated fatty acids can protect against Parkinson disease (21) (22) (23) . In autopsies of patients with Parkinson disease, significant amounts of Lewy bodies were found from brain specimens (24) . The Lewy bodies contain pathologic aggregates of a-synuclein, which is a 140-residue neuronal protein and, under physiologic conditions, is mainly found in presynaptic terminals. In addition to Parkinson disease, the Lewy bodies have been linked to multiple-system atrophy and dementia with Lewy bodies. These diseases are collectively referred to as synucleinopathies (25) . In vitro, elevated cell culture medium PUFA concentrations increase the concentration of a-synuclein (26) and have been shown to increase the rate of Lewy body formation in cultivated mesencephalic neurons (27) . In mice, inhibition of the expression of PARK2 had only a modest effect on the development of Parkinson disease (28) , whereas several extraneuronal effects of the Parkin ortholog Age-and sex-specific z scores of LDL cholesterol were used in all analyses. The table includes all SNPs that repeat with P , 0.01 and have same effect direction in the 2 Metabochip interaction scans performed in 5-and 7-y-old children. SNPs have been assigned to genes according to ScanDB. Chr, chromsome; NA, no known gene in proximity; SNP, single-nucleotide polymorphism. FIGURE 1 Serum LDL-cholesterol concentrations (6SEMs) in 5-y-old children in the Special Turku Coronary Risk Factor Intervention Project study by dietary fat quality and rs9364628 allele. A 2-tailed t test was used to compare 2 fat quality ratio groups in the TT genotype category. A linear interaction model was used to assess interaction between rs9364628 and the 2 fat quality ratio groups. The white boxes within the bars report the number of observations for each bar.
were discovered in a genetically modified Drosophila fruit fly (29) . These unexpected results have led to a wider characterization of the effects of Parkin deletion in mice. The Parkin knockout mice are resistant to high-fat, diet-induced weight gain, steatohepatitis, and insulin resistance. These effects may be mediated through alterations in lipid metabolism rather than the inability to use nutrients (20) . Currently, the roles of serum or dietary lipids in the development of Parkinson disease in humans have not been clarified.
The Finnish population is genetically exceptionally isolated compared with central European populations. Migration of a small founder population to Finland took place only a few thousand years ago (30) . Therefore, the probability for establishment of a new mutation is correspondingly greater. On the other hand, genetic association (or interaction in our case) studies are dependent on linkage disequilibrium (LD) between SNPs. Factors that increase LD include biochemical properties at the DNA level, ethnic admixture, demographic growth of the population, and selective sweeps (31) . By biochemical properties, we refer to yet unknown factors that create recombination hot spots that are not randomly scattered across the human genome (32) . Increased LD creates differences in haplotype block sizes across chromosomal regions. Because LD decays over time, the recent migration of the Finnish population through a genetic bottleneck 0.997
1 Age-and sex-specific z scores of LDL cholesterol were used in all analyses. Chr, chromosome; FDR, false-discovery rate; SNP, singlenucleotide polymorphism. 2 The genomic area selected for replication included SNPs 6200 kB from the discovery signal. 3 Number of SNPs replicated from the region. increases our chance of detecting genetic polymorphisms that are associated with a phenotype. The above-mentioned characteristics make the Finnish population particularly suitable for genetic studies.
We discovered the PARK2 SNP from the STRIP cohort, where more detailed nutritional data were available compared with what was available for the replication sample in the YFS cohort. Therefore, we selected a chromosomal region of 200 kB for replication analysis in the YFS to cover the entire haplotype block around the discovery signal. This LD block size corresponded to a 10-to 100-kB block size detected in a region inside an autosomal chromosome in a European-derived population (33) . The replication region might contain a more robust signal to account for the loss of statistical power due to the less precise dietary data in the replication sample. In addition, because the Metabochip used in the STRIP study is a targeted genotyping platform, the genome-wide panel used in the YFS may contain genetic variants that better tag the functional variant in the region.
Small sample size was a limitation in our study. Although large sample sizes are often needed in identifying SNPs associated with complex traits, recent studies demonstrate the success of finding some variants with sample sizes in the thousands or even hundreds (34, 35) . By using multiple follow-up measures, we were able to reduce random noise. In addition, our interest toward interaction term P values may reduce the statistical power to detect genetic variants. The lack of replication sometimes seen in GWASs may be partly caused by the differences in LD blocks. The replication failure might not always indicate that the initial discovery signal was a false positive, whereas the LD block difference may suggest that the same variants are not captured by genotyping arrays in 2 different study populations.
A further limitation of the study is the possibly incomplete data on the fat classes in the nutrient database (8) . For example, the combined palmitic and stearic acid intake (main sources of saturated fat) was about 9%, but the total saturated fat intake was about 13%. Such discrepancy is likely linked to incomplete data on the individual fatty acids in the nutrient database. This underestimation of individual fatty acid intakes is, however, likely random across the study population. The strengths of this study were the prospective longitudinal design that used extensive data from 2 cohort studies and careful statistical analysis.
In comparison with similar studies, the loss of follow-up has been low in both cohorts. Our simulation study, performed with artificial phenotype and real genotype data, demonstrated that a risk of a false-positive interaction did exist. However, replication of the genomic region in an independent cohort significantly reduced this possibility. The Metabochip used in the discovery phase is partly targeting the known lipid-associated SNPs from large cross-sectional studies, thus enriching our analyses with true lipid loci.
In conclusion, we identified that the PARK2 region might interact with dietary fatty acid composition to modify serum LDL-cholesterol concentrations. Although replication of our results in non-Finnish populations should be performed, our results suggest potential extraneuronal effects of PARK2 variants in humans, which could be assessed in longitudinal studies with serum metabolic profiling and nutritional information.
